4.5 Editorial Material

Stratifying patients for polypharmacy interventions: The case for a new biomarker?

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department

Anne Kathrine Bengaard et al.

Summary: The association between levels of medication use and health outcomes is dependent on baseline suPAR. Patients with low suPAR and hyper-polypharmacy have a higher risk of 90-day readmission and mortality. The impact of medication use is less pronounced in patients with high suPAR.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care

Christopher J. D. Threapleton et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Review Health Care Sciences & Services

Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis

Hanna E. Bloomfield et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study

Carol A. C. Coupland et al.

JAMA INTERNAL MEDICINE (2019)

Article Primary Health Care

Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials

Victor Johan Bernard Huiskes et al.

BMC FAMILY PRACTICE (2017)